(Total Views: 510)
Posted On: 05/04/2020 12:42:51 PM
Post# of 153908
Re: reallypeople? #31925
Quote:
The modified protocol is a Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Leronlimab in Patients with Coronavirus Disease 2019 (COVID-19) and calls for 75 planned patients in up to 10 centers in the United States. Patients enrolled in the trial are expected to have a treatment window of approximately 6 weeks.
(0)
(0)
